Table 1 |
||||
| Antibody tests against deamidated gliadin (dpgli) vs. native gliadin (ngli) in 149 CD patients and 119 controls | ||||
| IgA anti-ngli | IgA anti-dpgli | IgG anti-ngli | IgG anti-dpgli | |
| Sensitivity | 61% | 78% | 79% | 85% |
| Specificity | 97% | 97% | 68% | 92% |
| Positive predictive value | 97% | 97% | 76% | 93% |
| Negative predictive value | 67% | 78% | 72% | 83% |
McNemar’s test for significant changes p < 0.00001.
61 correct changes; 154 remain correct; 7 wrong changes; 46 remain wrong.
Bürgin-Wolff et al. BMC Gastroenterology 2013 13:19 doi:10.1186/1471-230X-13-19
